Patients with inflammatory bowel disease (IBD) are at increased risk for thromboembolic events, especially deep vein thrombosis (DVT) and pulmonary embolism (PE). This association was first described in 1936 by Bargen and Barker,
1 who described 18 patients with thromboembolic disease (predominantly venous) in more than 1000 patients treated for IBD at Mayo Clinic. Recent publications suggest that patients with IBD have increased risk of venous thromboembolism varying from as low as 1.5 times that of nonaffected patients
2,3 to as high as 4.7-fold for patients with Crohn disease in a population-based cohort study.
4 Moreover, patients with IBD who have PE appear to have increased risk of death compared with others.
2,5 Despite these findings, standard DVT and PE prophylaxis guidelines do not recommend enhanced prophylaxis for patients with IBD.
6-8 Recent data suggest that patients with IBD who require surgery are at very high risk for DVT. Scarpa et al
9 have reported that, compared with patients with cancer undergoing colon resections, patients with ulcerative colitis have an odds ratio (OR) of 7.4 for having postoperative DVT.